Citadel Advisors’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-691,458
Closed -$1.02M 7205
2022
Q2
$1.02M Sell
691,458
-3,512,608
-84% -$5.16M ﹤0.01% 3385
2022
Q1
$4.83M Buy
4,204,066
+3,427,731
+442% +$3.94M ﹤0.01% 2106
2021
Q4
$1.94M Buy
776,335
+736,685
+1,858% +$1.84M ﹤0.01% 3098
2021
Q3
$203K Sell
39,650
-27,199
-41% -$139K ﹤0.01% 5414
2021
Q2
$556K Sell
66,849
-5,447
-8% -$45.3K ﹤0.01% 4620
2021
Q1
$630K Sell
72,296
-731,872
-91% -$6.38M ﹤0.01% 4366
2020
Q4
$8.73M Buy
804,168
+600,305
+294% +$6.52M ﹤0.01% 1352
2020
Q3
$2.43M Buy
203,863
+76,526
+60% +$913K ﹤0.01% 2097
2020
Q2
$2.05M Buy
127,337
+86,422
+211% +$1.39M ﹤0.01% 2239
2020
Q1
$634K Buy
40,915
+16,520
+68% +$256K ﹤0.01% 3224
2019
Q4
$600K Sell
24,395
-551,496
-96% -$13.6M ﹤0.01% 3420
2019
Q3
$5.94M Buy
+575,891
New +$5.94M ﹤0.01% 1538
2019
Q2
Hold
0
5275
2019
Q1
Sell
-263,492
Closed -$1.62M 5211
2018
Q4
$1.62M Buy
263,492
+172,515
+190% +$1.06M ﹤0.01% 2393
2018
Q3
$964K Sell
90,977
-719,142
-89% -$7.62M ﹤0.01% 2747
2018
Q2
$11M Buy
810,119
+228,405
+39% +$3.09M 0.01% 965
2018
Q1
$10.3M Buy
581,714
+29,625
+5% +$526K 0.01% 932
2017
Q4
$6.93M Buy
552,089
+114,240
+26% +$1.43M ﹤0.01% 1145
2017
Q3
$8.34M Buy
+437,849
New +$8.34M 0.01% 1014
2016
Q4
Sell
-29,349
Closed -$289K 4272
2016
Q3
$289K Buy
+29,349
New +$289K ﹤0.01% 2823
2016
Q1
Sell
-7,245
Closed -$116K 4146
2015
Q4
$116K Sell
7,245
-18,964
-72% -$304K ﹤0.01% 3199
2015
Q3
$337K Buy
26,209
+16,970
+184% +$218K ﹤0.01% 2861
2015
Q2
$222K Sell
9,239
-31,048
-77% -$746K ﹤0.01% 2991
2015
Q1
$756K Sell
40,287
-10,688
-21% -$201K ﹤0.01% 2371
2014
Q4
$962K Sell
50,975
-176,600
-78% -$3.33M ﹤0.01% 2139
2014
Q3
$6.17M Buy
227,575
+211,993
+1,360% +$5.75M 0.01% 1089
2014
Q2
$485K Buy
+15,582
New +$485K ﹤0.01% 2302